Antiviral Activity of Ergoferon against Group A Rotavirus
- Авторы: Emelianova A.1, Shilovskii I.2, Sundukova M.2, Khaitov M.2, Epshtein O.1
-
Учреждения:
- Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathology and Pathophysiology, Research Institute of General Pathology and Pathophysiology
- State Research Center Institute of Immunology, Federal Medical-Biological Agency
- Выпуск: Том 161, № 6 (2016)
- Страницы: 806-807
- Раздел: Virology
- URL: https://journals.rcsi.science/0007-4888/article/view/237801
- DOI: https://doi.org/10.1007/s10517-016-3516-x
- ID: 237801
Цитировать
Аннотация
Antiviral activity of Ergoferon was studied in vitro on an experimental model of rotavirus infection in MA-104 cell line. In infected cells treated with Ergoferon, rotavirus titer was shown to decrease by 83 and 90% in comparison with cells treated with solvent used for Ergoferon preparation (p<0.05) and distilled water (p<0.05), respectively. These findings demonstrate high anti-rotavirus activity of Ergoferon.
Об авторах
A. Emelianova
Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathology and Pathophysiology, Research Institute of General Pathology and Pathophysiology
Автор, ответственный за переписку.
Email: agemelianova@gmail.com
Россия, Moscow
I. Shilovskii
State Research Center Institute of Immunology, Federal Medical-Biological Agency
Email: agemelianova@gmail.com
Россия, Moscow
M. Sundukova
State Research Center Institute of Immunology, Federal Medical-Biological Agency
Email: agemelianova@gmail.com
Россия, Moscow
M. Khaitov
State Research Center Institute of Immunology, Federal Medical-Biological Agency
Email: agemelianova@gmail.com
Россия, Moscow
O. Epshtein
Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathology and Pathophysiology, Research Institute of General Pathology and Pathophysiology
Email: agemelianova@gmail.com
Россия, Moscow